Perioperative medicine & outcomes

Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial

Intensive Care MedPublished Randomised controlled trial

Authors' conclusion

Among patients at risk for postoperative respiratory failure after emergency abdominal surgery, a strategy of individually adjusted highest PEEP in targeting driving pressure lower than 13 cmH2O did not reduce postoperative respiratory failure or death.

Study context

Population
Adults undergoing emergency abdominal surgery at risk for postoperative respiratory failure, 22 hospitals in France
Participants
338 vs 341
Comparison
Intervention vs Control
  • Interventionn = 338
  • Controln = 341reference
Primary endpoint
Composite of:
  • Postoperative respiratory failure (failure to wean from the ventilator or reintubation or curative NIV)
  • All-cause mortality
Follow-up
30 days
Methodological detailsmulticentre, pragmatic, assessor-masked
  • Multicentre
  • Pragmatic
  • Assessor-masked

Primary result

As reported in the abstract

Each group vs controlDifference (95% CI)
Intervention
5.5%(- 0.8 to 11.8)
Each group vs controlRelative risk (95% CI)P value
Intervention
1.27(0.96–1.68)
P = 0.08

Secondary outcomes

OutcomeDifference (95% CI)
Reintubation or curative NIVIntervention vs Control7.1% (2.5–11.9)
OutcomeRR (95% CI)P value
Reintubation or curative NIVIntervention vs Control1.97 (1.24–3.11)P = 0.004

Other secondary outcomes

Did not differ

Original publication

Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial. Intensive Care Med. Published 21 August 2025. doi:10.1007/s00134-025-08082-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.